Cipla

CIPLA · NSE · INR

1 344,00 ₹Variation par rapport à la clôture précédente: −0,15 %Variation absolue: −2,00 ₹

Clôture · 1 octobre 2026

Profil de la société

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - Specialty & Generic
Pays
Inde
Siège
Cipla House, 400013, Mumbai
Salariés
31 369
Cotation
CIPLA · NSE
Devise
INR
ISIN
INE059A01026
Site web
cipla.com